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Abstract
Background—Large datasets for investigating vaginal flora change at frequent, repeated
intervals are limited and graphical methods for exploring such data are inadequate. We report 2-
year weekly vaginal flora changes based on Gram stain using lasagna plots.
Methods—Weekly vaginal flora patterns were evaluated among 211 sexually experienced
women with 18 months or more of follow-up in Rakai, Uganda. Vaginal flora swabs were self-
collected weekly and categorized by Nugent Gram stain criteria (0–3, normal; 4–6, intermediate;
7–10, BV). Vaginal flora patterns were analyzed as the percentage of weekly observations with
BV (longitudinal prevalence) and illustrated by lasagna plots. Characteristics of women were
compared across tertiles of longitudinal prevalence of BV.
Results—Ninety-five percent of women had at least 1 episode of BV over 2 years with one-third
of women spending over half (52–100%) of their time with BV. Vaginal pH > 4.5 increased with
increasing tertiles of longitudinal prevalence of BV (p < 0.001). Weekly fluctuation in vaginal
flora states, as measured by a change in flora states from the prior to current visit, was highest in
the middle (41.9%) compared to the lower (30.1%) and upper tertiles (27.8%, p < 0.001). HIV
status and reported vaginal symptoms did not differ significantly across BV tertiles.
Conclusions—Women exhibited different patterns of vaginal flora changes over time, which
could not be described by baseline behaviors. Lasagna plots aided in describing the natural history
of BV within and across women and may be applied to future BV natural history studies.
Introduction
Bacterial vaginosis (BV) is the most common vaginal syndrome among reproductive-aged
women and is marked by a shift in the normal Lactobacillus-dominant flora to a more
diverse flora consisting of commensal anaerobic bacteria.1 Clinically, BV is characterized
by vaginal discharge, odor, and an increased vaginal pH (> 4.5); however, symptoms are
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nonspecific and as many as 50% of women remain asymptomatic.2, 3 Women with BV are
more likely to experience reproductive and obstetric complications, including preterm birth,
low birth weight, and sexually transmitted infections.4 Despite its prevalence and adverse
sequelae, the etiology and natural history of BV are poorly understood.
The dynamics of vaginal flora variability over time within women add to the complexity of
studying this condition. A recent NIH workshop on BV research priorities stressed the need
for larger studies with more frequent, prospective sampling.1 Longitudinal studies of vaginal
flora change with infrequent observations are likely to miss episodes of BV or to detect
transient BV, rather than documenting the full variability of vaginal flora patterns. A limited
number of studies with frequent, repeated measurements have investigated short-term
fluctuations in vaginal microflora at daily or weekly intervals; however, these studies were
constrained by small sample sizes and short study duration.5–12 In addition, the display of
vaginal flora patterns over time was often limited to a few individuals’ representative
patterns rather than utilizing the entirety of the data across all individuals. This limitation is
further complicated by inadequate graphical methods for large longitudinal datasets, such as
spaghetti plots, which can lead to multiple, intersecting lines that can obscure trends and
patterns.13 Establishing patterns and adequate display of vaginal flora trajectories within and
between women over time is needed from large studies to better understand the natural
history of BV.
We report data from a cohort of ever sexually active, reproductive-aged women in Rakai,
Uganda followed weekly for up to two years and classify women according to their
longitudinal vaginal flora profile. Vaginal flora patterns within and between women are
illustrated using lasagna plotting, which is a recently developed exploratory method for
representing and summarizing longitudinal, categorical data across a large sample of
individuals.13
Materials and Methods
A two-year cohort study was conducted between 2001 and 2003 among 312 consenting
females aged 13–39 years in rural Rakai District, Uganda. Women who were sexually active
and postmenarcheal at baseline (N=255) and who remained in the study for at least 18
months of observation (N=211, 82.7% of the eligible sample) were included in this analysis.
Ethical approval for this study was provided by institutional review boards (IRBs) in
Uganda (the Scientific and Ethics Committee of the Uganda Virus Research Institute) and
the United States (the Johns Hopkins Bloomberg School of Public Health IRB and the
Columbia University Medical Center IRB).
The study design and data collection has been described previously.14 Briefly, women were
enrolled regardless of HIV status, pregnancy, or sexual history. Participants were
interviewed in their homes every week for up to 2 years and provided a self-collected
vaginal swab for BV and vaginal pH assessment. More detailed questionnaires were
administered at baseline, monthly, and 6-monthly visits. Self-collected vaginal swabs were
rolled onto slides and air dried, Gram stained, and assessed using the Nugent quantitative
morphologic classification for vaginal flora.15 Vaginal flora status based on the Nugent
score was defined as: normal (0–3 points), intermediate (4–6 points), or bacterial vaginosis
(7–10 points). Vaginal pH was determined by BAKER-pHIX pH papers (pH range: 4.0–9.0,
Phillipsburg, NJ) affixed to a pediatric tongue depressor and assessed during all non-
menstruating visits.
A serologic sample was analyzed for HIV every 6 months using two HIV enzyme
immunosorbent assays (Vironostika HIV-1, Organon Teknicka, Charlotte, North Carololina,
Thoma et al. Page 2
Sex Transm Dis. Author manuscript; available in PMC 2012 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
USA; Cambridge Biotech, Worcester, MA, USA) and Western blot (HIV-1 Western Blot,
BioMerieuz-Vitek, St. Louis, MI, USA) for discordant results. InPouch TV culture (BioMed
Diagnostics, San Jose, CA) was used for Trichomonas vaginalis (TV) detection from
vaginal swabs collected every 6 months. At baseline and monthly, urinary hCG was assessed
for pregnancy in all women who were not visibly pregnant, had a last menstrual period over
30 days prior to the visit, were not using Depo Provera, or had lactational amenorrhoea.
Self-reported abnormal genital discharge, dysuria, and ulcers were treated syndromically,
using a single, directly observed 2 gram dose of metronidazole for discharge, which was one
of the recommended regimens for BV during the study period16. Persistent abnormal
discharge was treated with 1 gram dose of Azithromycin or 400 mg of Cefixime for
pregnant women. Self-reported treatment was used in the analysis.
Statistical Methods
For women who completed up to 18 to 24 months of follow-up, we estimated the percentage
of follow-up time spent in a given vaginal flora state, which is referred to as “longitudinal
prevalence” and is often used to represent the prevalence of common recurrent infections,
such as episodes of diarrhea or respiratory infections, in the same individual over time. 17
For example, the longitudinal prevalence of BV was estimated by calculating the total
number of visits with BV divided by the total number of observations per woman and,
subsequently, divided into tertiles. This calculation was also applied to estimate the average
frequency (percentage) of time women spent with: normal and intermediate vaginal flora
states, vaginal pH greater than 4.5, self-reported vaginal symptoms and treatment, menses,
pregnancy, weekly sex, new partners in the past month, and substances inserted into the
vagina in the past month. The frequency of vaginal flora state transitioning within a woman
was estimated by the number of times the prior weekly state differed from the current state
divided by the total number of paired, consecutive visits observed.
Vaginal flora patterns within and between women over time were represented by lasagna
plots, which is an exploratory graphical method proposed by Swihart et al. for use in large
longitudinal epidemiologic studies and analogous to heat maps often used in the genomics
literature.13,18 This method was developed to overcome limitations of the spaghetti plot for
visualizing longitudinal data, which is subject to overlapping trajectories, indistinguishable
data patterns, and difficulties in displaying missing data. In contrast, lasagna plots allow for
visualization of transitional, categorical data and simultaneous illustration of individual and
group level (e.g., women grouped according to an external covariate, such as age)
information for large groups of individuals. Briefly, the visualization of transitional data can
be represented by an m × n history matrix H, where m rows are the number of individuals
and n columns are the number of repeated intervals. Thus, each row represents the subject-
specific data across n intervals. Graphical visualization of the data is achieved by assigning
colors to each element hij based on the vaginal flora status (normal, intermediate, or BV) for
that visit. In addition, this framework allows for row, column, and cluster sorting facilitating
the graphical display of information and patterns in the data. This method precludes
overlapping of trajectories to better reveal trends and patterns.
BV and other vaginal flora states vary over time and are subject to remission and recurrence
for different lengths of time across individuals. Two matrices were generated to illustrate
these data using lasagna plots. The first matrix (Figure 1) illustrates the temporal ordering of
vaginal flora states and transitions across individuals (Y-axis) over time (X-axis). The
second matrix (Figure 2) sorts vaginal flora states within each individual to display the
proportion of follow-up time spent with BV (longitudinal prevalence of BV). Both figures
order women by their longitudinal prevalence of BV from lowest to highest and are divided
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into tertiles of this distribution. Lasagna plots were generated using R 2.8.1 statistical
software.19
Baseline characteristics and longitudinal frequencies were compared by tertiles of
longitudinal prevalence of BV. Baseline associations were assessed by chi-squared tests for
categorical variables and one-way ANOVA for continuous variables. Medians and
interquartile ranges (IQR) of 2-year longitudinal frequencies were compared by Kruskal
Wallis one-way analysis of variance with correction for ties. A two-sided p-value of 0.05
was used to assess statistical significance. Data were analyzed using Stata/SE 10.0 for
Windows (Stata Corporation, College Station, TX).
Results
There were a total of 255 ever sexually active, postmenarcheal women at baseline. The
mean age of participants at baseline was 24.7 years (SD = 6.4) with 25.7% aged 14–19
years. Eleven percent were HIV-positive and almost half of the women (47.6%) had BV at
enrollment. Four women seroconverted to HIV by the end of follow-up. Participant retention
rates were high with 211 (82.7%) women remaining under observation beyond 18 months
and contributing an average of 83.6 (SD = 8.2) weekly visits per woman, which constitutes
an 86.2% compliance with the weekly visit schedule over 24 months. Losses to follow-up
were 6.3%, 5.9%, and 5.1% by 6 months, 6–12 months, and 12–18 months, respectively.
Of the 211 women observed for 18 months or more of observation, there were 71 women in
the lowest tertile (0–19.3% longitudinal prevalence of BV), 70 women in the middle tertile
(20.2–52.2% longitudinal prevalence of BV), and 70 in the upper tertile (52.3–100%
longitudinal prevalence of BV). The vaginal flora patterns are depicted by lasagna plots in
Figures 1 and 2 and ordered by each woman’s longitudinal prevalence of BV from lowest to
highest. Figure 1 illustrates temporal transitioning between weekly vaginal flora states. In
the lowest tertile, most of the women had persistent normal vaginal flora (light blue) with
transient intermediate status (red) or BV (black ) episodes. In the upper tertile, most of the
women had persistent BV over two years with some transitory intermediate episodes and
resolution to normal flora. The middle tertile showed the greatest fluctuation between
vaginal flora states over time. Figure 1 also shows a cluster of missing observations (off-
white boxes) that occurred around 36 and 84 weeks of observation, which correspond to the
Christmas and New Years holiday and are similar in timing across all tertiles of longitudinal
prevalence. Figure 2 is a within-woman sort on BV status (i.e. collapsed over time) to
display the total time each women spent in BV, intermediate and normal flora states. Almost
all women had BV for at least one visit during follow-up (n=202, 95.7%) and women at the
bottom of the figure spent almost their entire observation time in a BV state.
Comparisons of the sociodemographic, behavioral, and clinical characteristics by tertiles of
longitudinal prevalence of BV are shown in Table 1. Most baseline characteristics did not
differ significantly between tertiles of longitudinal prevalence with the exception of baseline
vaginal flora status, in which the enrollment prevalence of BV significantly increased with
increasing tertiles of longitudinal prevalence of BV (12.7%, 55.1%, and 74.3% for lower,
middle, and upper tertiles, respectively, p < 0.001). Differences in mean age at first sex and
sex with a circumcised partner were of borderline significance (p = 0.07 and 0.13,
respectively).
Transitioning between Nugent score categories (normal, intermediate or BV) per woman
was highest for the middle tertile (median: 41.9%, IQR: 33.3–50.8%) compared to the lower
tertile (median: 30.1%, IQR: 22.0–39.2%) and upper tertiles (median: 27.8%, IQR: 17.9–
39.0%, p < 0.001). Women in the upper tertile spent the greatest amount of time in a BV
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state (median: 69.8%, IQR: 61.6–85.5), the middle tertile in an intermediate state (median:
20.0%, IQR: 15.1–30.2), and the lowest tertile in a normal vaginal flora state (median:
76.1%, IQR: 67.9–86.2). A high vaginal pH (pH > 4.5) was the only clinical predictor that
increased significantly with increasing tertiles of longitudinal prevalence (p < 0.001).
Reported frequencies of vaginal discharge or odor and treatment for vaginal symptoms were
low and not significantly different across all 3 tertiles. Restricting the analysis to those who
experienced any symptom of discharge, odor, or received treatment, did not change
inference (p = 0.79, 0.28, and 0.91, respectively). There were no differences in the frequency
of reported sex in the past week, pregnancy status, substances inserted into the vagina new
sex partners, and swabs collected during menstruation across tertiles (data not shown).
Finally, the pattern of missing visits appears to be fairly consistent across all individuals and
there were no differences in the average number of observed visits per tertile (lower = 83.7,
middle = 83, and upper = 84.2, p = 0.70).
Discussion
Among women in rural Rakai, Uganda, BV was common with 95% of women having at
least 1 weekly episode of BV diagnosed by Nugent Gram stain criteria over a 2-year period.
Apart from a woman’s starting vaginal flora state, there were few baseline characteristics
that predicted differences across tertiles of longitudinal prevalence of BV. Our data also
indicate that vaginal symptoms of discharge and odor did not vary across different patterns
of vaginal flora, but that the frequency of high vaginal pH (pH > 4.5) increased with
increasing tertiles of longitudinal prevalence of BV. Lasagna plots further illustrated
temporal patterns in vaginal flora and graphically illustrated the duration of onset and
remission of BV, transitions between vaginal flora states, and the overall proportion of time
spent in a given vaginal flora state within and between women. Incorporating measures of
chronicity, such as longitudinal prevalence, into future BV studies may better describe the
burden of BV in women.
Women in the upper tertile of longitudinal prevalence of BV tended to persist in a BV state.
It has been suggested that women with persistent BV may represent a unique group with
distinct vaginal flora that differ from women with less frequent or no BV occurrences.20 It
has also been hypothesized that specific bacteria in women with persistent BV by Nugent
criteria may maintain a healthy vaginal environment, as defined by lactic acid production
and low vaginal pH, despite the lack of lactobacilli.21 However, this assertion was not
supported by our data, which shows an increasing percentage of women with a vaginal pH >
4.5 associated with increasing tertiles of longitudinal prevalence of BV (Table 1). Women in
the middle tertile of longitudinal prevalence of BV had the highest frequency of
transitioning between vaginal flora states. While transient shifts in BV status may be
influenced by recent sex or menstruation22, this association was not reflected across tertiles
of longitudinal prevalence of BV. Thus, other factors, such as vaginal bacterial composition,
may explain the higher frequency of transitioning in this group over a 2-year period.
There was some evidence to suggest that women who had predominantly normal flora
throughout follow-up (lower tertile) were more likely to initiate sex at a later age and have a
circumcised partner compared to those with moderate or frequent BV occurrences.
Uncircumcised men may increase their partner’s exposure to anaerobic bacteria leading to
more vaginal flora changes,23 and greater BV prevalence.24
There were few differences in clinical factors across tertiles of longitudinal BV prevalence.
The prevalence of T. vaginalis was higher in middle and upper tertiles; however, the number
of women with T. vaginalis was low and was not statistically significant. Longitudinal
studies evaluating BV prevalence in HIV-positive women are conflicting and show either no
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effect or increased risk in HIV-positive women.25, 26 However, both studies supported a
protective effect of treatment, higher CD4 cell counts, or lower viral load on BV among
HIV-positive women. In this study, there were a total of 21 HIV-positive women who most
likely represented women at an earlier stage of HIV infection. Finally, it is unknown why
some women develop symptoms of BV and others do not. We did not find that the
frequency of self-reported vaginal symptoms varied by greater persistence of high Nugent
scores over time. While asymptomatic BV has been associated with adverse health
outcomes, there is some debate regarding the utility of Nugent scores for defining a
“healthy” vaginal flora environment.27 Nevertheless, the Nugent score method continues to
be recommended as the gold standard until new diagnostic methods are developed.1
This study is unique in that it provides a data-rich structure for evaluating the natural history
of BV at weekly intervals over 2 years. In addition, we presented methods for illustrating
and exploring trends in transitional, categorical data. However, our analyses were limited to
use of Nugent score morphology, which does not provide information on bacterial
composition and abundance that may influence vaginal flora trajectories. In addition,
findings from these rural Ugandan women may not be generalizable to other populations.
We previously reported a cross-sectional prevalence of BV in this study population of
47.6% 28, which is similar to the prevalence of non-Hispanic black women in the United
States (51.4%). 29 Comparisons of the longitudinal prevalence of BV by race in the United
States and other populations are warranted.
In summary, BV was common and tended to be persistent in this population. The use of
longitudinal prevalence of BV, illustrated by lasagna plots provides a new approach to the
analysis of vaginal flora in large populations with frequent sampling. Future research should
explore the vaginal microbiota using molecular technologies to further elucidate bacterial
communities in women with different durations of time spent with BV.
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Figure 1. Subject-specific vaginal flora transition states by weekly visits ordered by the 2-year
longitudinal prevalence of BV from lowest to highest
In the graph, light blue boxes correspond to normal flora, red boxes to intermediate flora,
black boxes to BV, and off-white boxes to missing visits. Yellow lines divide women based
on tertiles of their longitudinal prevalence of BV from lowest to highest.
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Figure 2. The 2-year longitudinal prevalence of BV per woman ordered from lowest to highest
In the graph, light blue bars correspond to normal vaginal flora, red bars to intermediate
flora, black bars to BV, and off-white bars to missing visits. Yellow lines divide women
based on tertiles of their longitudinal prevalence of BV from lowest to highest. [This figure
represents a within-row sort of BV states from Figure 1].
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Table 1
Baseline descriptive characteristics and longitudinal frequency of vaginal flora and vaginal symptoms by
lower, middle, and upper tertiles of the longitudinal prevalence of BV
Lower Middle Upper p-valuea
Total (n = 211) 71 70 70 -
Baseline characteristicsb
Mean (SD) age (years) 25.2 (6.5) 25.7 (6.3) 24.4 (6.4) 0.50
Age groups
 14–19 13 (18.3) 16 (22.9) 21 (30.0)
 20–29 38 (53.5) 36 (51.4) 34 (48.6)
 30–39 20 (28.1) 18 (25.7) 15 (21.4) 0.58
Mean (SD) age at first sex (years) 16.1 (2.2) 15.5 (1.8) 15.4 (1.9) 0.07
Currently married
 No 20 (28.1) 23 (32.9) 25 (35.7) 0.63
 Yes 51 (71.8) 47 (67.1) 45 (64.3)
Hormonal contraceptive use
 No 52 (73.4) 46 (65.7) 49 (70.0)
 Yes 14 (19.7) 18 (25.7) 14 (20.0)
 Pregnant at baseline 5 (7.0) 6 (8.6) 7 (10.0) 0.85
Sex partners in the past 5 yearsc
 1 59 (83.1) 54 (78.3) 49 (70.0)
 2+ 12 (16.9) 15 (21.7) 21 (30.0) 0.17
Condom used
 Never 44 (62.0) 47 (67.1) 41 (58.6)
 Inconsistent 20 (28.1) 13 (18.6) 19 (27.1)
 Consistent 7 (9.9) 10 (14.3) 10 (14.3) 0.61
Partner’s circumcision statusd
 Uncircumcised 40 (58.8) 51 (72.9) 51 (72.9)
 Circumcised 28 (41.2) 19 (27.1) 19 (27.1) 0.13
HIV status
 Negative 64 (90.1) 63 (90.0) 61 (89.7)
 Positive 7 (9.9) 7 (10.0) 7 (10.3) 0.99
Trichomonas vaginalis
 Negative 64 (97.0) 56 (90.3) 60 (90.9)
 Positive 2 (3.0) 6 (9.7) 6 (9.1) 0.27
Baseline vaginal flora status
 Normal 39 (54.9) 18 (26.1) 8 (11.4)
 Intermediate 23 (32.4) 13 (18.8) 10 (14.3)
 BV 9 (12.7) 38 (55.1) 52 (74.3) <0.001
2-year Longitudinal Frequencye
Vaginal flora states
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Lower Middle Upper p-valuea
Total (n = 211) 71 70 70 -
 Bacterial Vaginosis 7.9 (3.5–12.6) 37.3 (28.6–45.6) 69.8 (61.6–85.5) <0.001
 Intermediate Flora 13.8 (9.6–21.6) 20.0 (15.1–30.2) 11.8 (6.8–20.2) <0.001
 Normal Flora 76.1 (67.9–86.2) 42.4 (32.1–52.1) 11.9 (6.2–22.2) <0.001
Transitions between flora states 30.1 (22.0–39.2) 41.9 (33.3–50.8) 27.8 (17.9–39.0) <0.001
Vaginal Symptoms
 Discharge 0 (0–2.2) 0 (0–2.3) 0 (0–2.4) 0.65
 Odor 0 (0–0) 0 (0–1.1) 0 (0–0) 0.23
Treatment for Vaginal Symptoms 1.6 (0–4.3) 1.5 (0–5.1) 1.6 (0–4.5) 0.82
Vaginal pH > 4.5 64.0 (54.3–72.8) 74.9 (68.2–84.0) 83.7 (76.0–88.4) <0.001
NOTE: Totals may vary due to missing responses or test results
a
Baseline characteristics are compared using chi-squared or ANOVA tests; longitudinal summary measures are compared using Kruskal-Wallis
one-way analysis of variance with correction for ties
b
Data are presented as n (%) unless specified otherwise, SD = standard deviation
c
One person reported no partners in the past 5 years and was grouped as having 1 partner
d
Most recent male partner
e
Data are presented as median (IQR) percentage of visits, IQR = interquartile range
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